The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in ...
Learn more about whether Celldex Therapeutics, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results